Journey Medical Corp Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $66.9M+21.3% YoYTTM through 30 Jun 2026
Net Income -$6.1MTTM through 30 Jun 2026
Free Cash Flow -$22.5MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 66.2% |
| EBITDA Margin | -4.5% |
| Operating Margin | -13.2% |
| Net Margin | -9.1% |
Returns
-37.0%ROE
-12.5%ROA
Balance Sheet Health
Debt / Equity0.82x
Current Ratio1.72x
Net Debt$1.3M
Cash & Equivalents$25.6M
Quality Metrics
Altman Z-Score1.32
Piotroski F-Score3 / 9
FCF Margin-33.6%
Rule of 40-10.1
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2025: $61.9M
Diluted EPS-$0.22TTMFY2025: $-0.47
Dividend
No dividend
Capital Allocation
R&D Spend$495K
Capex Intensity22.4%
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.